Divisions: Global Health

1 – 10 of 58
  • Lynda Stuart

    Lynda Stuart

    Dr. Lynda Stuart led the Vaccine and Host Pathogen Biology domain of the Discovery and Translational Sciences team.

  • Gates Foundation placeholder image for leadership.

    Skip Virgin

    Skip Virgin leads a team that works to develop novel, AI-enabled approaches to drug discovery for curative interventions to virally induced chronic diseases.

  • Mike McCune

    Mike McCune

    Mike McCune leads a team that works to develop novel gene-based curative interventions for HIV and sickle cell disease.

  • Jenni Weisman

    Jennifer Weisman

    Jenni Weisman leads a team that scopes out new program areas for development and builds external collaborations. Her role also includes leading internal business operations and portfolio management for the…

  • Nina Russell

    Nina Russell

    Dr. Nina Russell oversees the foundation’s investments in vaccine and drug development to prevent and treat tuberculosis (TB) and HIV.

  • David Robinson

    David Robinson

    David Robinson oversees the foundation’s work with partners to harness advances in chemistry, manufacturing, and controls (CMC) to develop new vaccines against diseases including polio.

  • Pervin Anklesaria

    Pervin Anklesaria

    Pervin Anklesaria leads the HIV vaccines and biologics prevention efforts for the foundation’s HIV team.

  • Helen Jamet

    Helen Jamet is a medical entomologist with more than 20 years of experience in malaria prevention, research and vector control product development.

  • Edward Wenger

    Edward Wenger

    Edward Wenger sets the overall technology vision at the Institute for Disease Modeling and leads teams that support product development and surveillance design.

  • Jennifer Gardy

    Jennifer Gardy

    Jennifer Gardy joined the foundation in 2019 as deputy director for Surveillance, Data, and Epidemiology for the Malaria team and since 2021 has also served as a deputy director for…